Annarita Nappi

Dr. Annarita Nappi

University of Naples Federico II, Naples, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Redox Biology
Verified
Journal Article
Open access
SSSerena Sagliocchi
Serena Sagliocchi
ACAnnunziata Gaetana Cicatiello
Annunziata Gaetana Cicatiello
ECEmery Di Cicco
Emery Di Cicco
RARaffaele Ambrosio
Raffaele Ambrosio
CMCaterina Miro
Caterina Miro
Monica DenticeMonica Dentice
Monica Dentice
Thyroid hormone (TH) is a key metabolic regulator that acts by coordinating short- and long-term energy needs. Accordingly, significant metabolic changes are observed depending on thyroid status. Although it is established that hyperthyroidism augments basal energy consumption, thus resulting in an enhanced metabolic state, the net effects on cellular respiration and generation of reactive oxygen species (ROS) remain unclear. To elucidate the effects of augmented TH signal in muscle cells, we generated a doxycycline-inducible cell line in which the expression of the TH-activating enzyme, type 2 deiodinase (D2), is reversibly turned on by the "Tet-ON" system. Interestingly, increased intracellular TH caused a net shift from oxidative phosphorylation to glycolysis and a consequent increase in the extracellular acidification rate. As a result, mitochondrial ROS production, and both the basal and doxorubicin-induced production of cellular ROS were reduced. Importantly, the expression of a set of antioxidant genes was up-regulated, and, among them, the mitochondrial scavenger Sod2 was specifically induced at transcriptional level by D2-mediated TH activation. Finally, we observed that attenuation of oxidative stress and increased levels of SOD2 are key elements of the differentiating cascade triggered by TH and D2, thereby establishing that D2 is essential in coordinating metabolic reprogramming of myocytes during myogenic differentiation. In conclusion, our findings indicate that TH plays a key role in oxidative stress dynamics by regulating ROS generation. Our novel finding that TH and its intracellular metabolism act as mitochondrial detoxifying agents sheds new light on metabolic processes relevant to muscle physiology.

27 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
CMCaterina Miro
Caterina Miro
ECEmery Di Cicco
Emery Di Cicco
RARaffaele Ambrosio
Raffaele Ambrosio
GMGiuseppina Mancino
Giuseppina Mancino
DGDaniela Di Girolamo
Daniela Di Girolamo
Monica DenticeMonica Dentice
Monica Dentice
Epithelial tumor progression often involves epithelial-mesenchymal transition (EMT). We report that increased intracellular levels of thyroid hormone (TH) promote the EMT and malignant evolution of squamous cell carcinoma (SCC) cells. TH induces the EMT by transcriptionally up-regulating ZEB-1, mesenchymal genes and metalloproteases and suppresses E-cadherin expression. Accordingly, in human SCC, elevated D2 (the T3-producing enzyme) correlates with tumor grade and is associated with an increased risk of postsurgical relapse and shorter disease-free survival. These data provide the first in vivo demonstration that TH and its activating enzyme, D2, play an effective role not only in the EMT but also in the entire neoplastic cascade starting from tumor formation up to metastatic transformation, and supports the concept that TH is an EMT promoter. Our studies indicate that tumor progression relies on precise T3 availability, suggesting that pharmacological inactivation of D2 and TH signaling may suppress the metastatic proclivity of SCC.

5 February 2022 in Cancer Letters
Verified
Journal Article
Closed access
CMcaterina miro
caterina miro
AGAngelo Di Giovanni
Angelo Di Giovanni
MMMelania Murolo
Melania Murolo
ACAnnunziata Gaetana Cicatiello
Annunziata Gaetana Cicatiello
Annarita NappiAnnarita Nappi
Annarita Nappi
Monica DenticeMonica Dentice
Monica Dentice

1 October 2020 in European Journal of Cancer
Verified
Journal Article
Closed access
CCClaudia Cardone
Claudia Cardone
BBBernadette Blauensteiner
Bernadette Blauensteiner
Veronica Moreno-ViedmaVeronica Moreno-Viedma
Veronica Moreno-Viedma
GMGiulia Martini
Giulia Martini
VSVittorio Simeon
Vittorio Simeon
EMErika Martinelli
Erika Martinelli

4 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
Annarita NappiAnnarita Nappi
Annarita Nappi
CMCaterina Miro
Caterina Miro
APAntonio Pezone
Antonio Pezone
ATAlfonso Tramontano
Alfonso Tramontano
ECEmery Di Cicco
Emery Di Cicco
Monica DenticeMonica Dentice
Monica Dentice
The Thyroid Hormone (TH) activating enzyme, type 2 Deiodinase (D2), is functionally required to elevate the TH concentration during cancer progression to advanced stages. However, the mechanisms regulating D2 expression in cancer still remain poorly understood. Here, we show that the cell stress sensor and tumor suppressor p53 silences D2 expression, thereby lowering the intracellular THs availability. Conversely, even partial loss of p53 elevates D2/TH resulting in stimulation and increased fitness of tumor cells by boosting a significant transcriptional program leading to modulation of genes involved in DNA damage and repair and redox signaling. In vivo genetic deletion of D2 significantly reduces cancer progression and suggests that targeting THs may represent a general tool reducing invasiveness in p53-mutated neoplasms.

29 April 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Annarita NappiAnnarita Nappi
Annarita Nappi
MMMelania Murolo
Melania Murolo
ACAnnunziata Gaetana Cicatiello
Annunziata Gaetana Cicatiello
SSSerena Sagliocchi
Serena Sagliocchi
ECEmery Di Cicco
Emery Di Cicco
CMcaterina miro
caterina miro
Skeletal muscle is a key energy-regulating organ, skilled in rapidly boosting the rate of energy production and substrate consumption following increased workload demand. The alteration of skeletal muscle metabolism is directly associated with numerous pathologies and disorders. Thyroid hormones (THs) and their receptors (TRs, namely, TRα and TRβ) exert pleiotropic functions in almost all cells and tissues. Skeletal muscle is a major THs-target tissue and alterations of THs levels have multiple influences on the latter. However, the biological role of THs and TRs in orchestrating metabolic pathways in skeletal muscle has only recently started to be addressed. The purpose of this paper is to investigate the muscle metabolic response to TRs abrogation, by using two different mouse models of global TRα- and TRβKO. In line with the clinical features of resistance to THs syndromes in humans, characterized by THRs gene mutations, both animal models of TRs deficiency exhibit developmental delay and mitochondrial dysfunctions. Moreover, using transcriptomic and metabolomic approaches, we found that the TRs–THs complex regulates the Fatty Acids (FAs)-binding protein GOT2, affecting FAs oxidation and transport in skeletal muscle. In conclusion, these results underline a new metabolic role of THs in governing muscle lipids distribution and metabolism.